Anacacia Capital related stories
All articles and analysis
Privately Speaking: Tim Sims of Pacific Equity PartnersPacific Equity Partners introduced the buyout in Australia over a decade ago and has consistently raised the country’s largest funds. As it prepares to raise Fund V in a difficult climate, co-founder and managing director Tim Sims tells Drew Wilson that PEP still has an edge over its local and international rivals
- Anacacia in 5x trade sale exit
Sydney-based Anacacia has exited an appliances company to an Australian corporate buyer and will soon close its second fund.
- Anacacia exits Rafferty’s in £42m trade sale
The Australian country manager has sold its investment in the baby-food manufacturer to UK-listed PZ Cussons, just a month after Australian regulators blocked a bid from Heinz & Co.
- Reuters - Australian Regulator Blocks Heinz Infant Food Deal
Australia's competition regulator has blocked an attempted takeover of Rafferty's Garden, an organic baby food supplier, by U.S.-based food giant H.J. Heinz Co on concerns that the deal would have reduced competition significantly, writes Reuters. By blocking the deal, the regulator has served up a setback for Anacacia Capital, the company's private equity owner, which invested in Rafferty's in 2010 through a management buyout.
- Anacacia raises A$125m for second vehicle
The Australian private equity firm has made a second close on its latest fund, exceeding its original target of A$100m.
- Former ANZ Capital private equity director sets up own firm(2)
Jeremy Samuel, previously a director of private equity at Sydney-based ANZ Capital, is planning to operate Anacacia Capital in less competitive waters.
- Former ANZ Capital private equity director sets up own firm
Jeremy Samuel, previously a director of private equity at Sydney-based ANZ Capital, is planning to operate Anacacia Capital in less competitive waters.
- Anacacia Capital Completes Lomb Scientific Exit to Thermo Fisher Scientific
Australian mid-market LBO shop Anacacia Capital exited Lomb Scientific, selling it to Thermo Fisher Scientific Inc. for an undisclosed sum. A source familiar with the transaction said the PE firm bagged an 80% IRR on its investment following a three-year hold. For Thermo Fisher, the transaction represents a continued trend throughout 2010 of buying private backers’ assets. In May, it bought Fermentas International from investors including Summit Partners and in March the company completed a deal to buy Ahura Scientific, which raised funds from investors including ARCH Venture Partners and Fuse Capital.
- PE Week Wire: Wednesday, July 16, 2008
Tyranny of the Relativists